作者: Augustinus Bader
DOI:
关键词: Matrix (biology) 、 Endocrinology 、 Internal medicine 、 Ciliary neurotrophic factor 、 Leukemia inhibitory factor 、 Growth hormone 、 Erythropoietin 、 Chemistry 、 Cell biology 、 Somatostatin 、 Thrombopoietin 、 Human growth hormone
摘要: The invention relates to an in-vitro and in-vivo method for multiplying differentiating cells, during which the growth process of cells is initiated or terminated structurally directed by use factors thrombopoietin (TPO) and/or erythropoietin (EPO), hormone (GH), particularly human (HGH), somatostatin leukemia inhibitory factor (LIF) ciliary neurotropic (CNTF). also a biological matrix supporting structure containing aforementioned factors, device production thereof carrying out inventive method.